J&J’s one-shot Covid vaccine approved in Europe but supply questions linger

cnbc2021-03-11

KEY POINTS Europe’s drug regulator on Thursday approved the one-dose coronavirus vaccine created by Johnson & Johnson. The approval adds another weapon to the armory in use against the virus. Supply ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1124370726?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-03-11 21:34","share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","id":"1124370726","market":"us","top_or_hot":-1,"title":"J&J’s one-shot Covid vaccine approved in Europe but supply questions linger","media":"cnbc","content":"<div>\n<p>KEY POINTS\n\nEurope’s drug regulator on Thursday approved the one-dose coronavirus vaccine created by Johnson & Johnson.\nThe approval adds another weapon to the armory in use against the virus.\nSupply ...</p>\n\n<a href=\"https://www.cnbc.com/2021/03/11/jjs-one-shot-covid-vaccine-approved-by-europe.html\">Source Link</a>\n\n</div>\n","source":"cnbc_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>J&J’s one-shot Covid vaccine approved in Europe but supply questions linger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJ&J’s one-shot Covid vaccine approved in Europe but supply questions linger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-11 21:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/03/11/jjs-one-shot-covid-vaccine-approved-by-europe.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nEurope’s drug regulator on Thursday approved the one-dose coronavirus vaccine created by Johnson & Johnson.\nThe approval adds another weapon to the armory in use against the virus.\nSupply ...</p>\n\n<a href=\"https://www.cnbc.com/2021/03/11/jjs-one-shot-covid-vaccine-approved-by-europe.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"JNJ","symbol_name":"强生","start_time":0,"source_url":"https://www.cnbc.com/2021/03/11/jjs-one-shot-covid-vaccine-approved-by-europe.html","article_id":"1124370726","we_media_id":null,"thumbnails":[],"rights":{"source":"cnbc_highlight","url":"https://www.cnbc.com/2021/03/11/jjs-one-shot-covid-vaccine-approved-by-europe.html","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.ArticleHeader-headline{#titleStyle#}a{#lv2TextColor#}.ArticleHeader-time, .Author-authorNameAndSocial a{#sourceStyle#;}","selectors":".PageBuilder-pageWrapper","filters":".ArticleHeader-eyebrow, .RelatedTags-relatedTags","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=1124370726","pubTimestamp":1615469642,"columns":[],"sourceInfo":{"source_id":"cnbc_highlight","name":"CNBC"},"weMediaInfo":null,"summary":"KEY POINTS\n\nEurope’s drug regulator on Thursday approved the one-dose coronavirus vaccine created by","collect":0,"end_time":0,"defaultTopTitle":"cnbc.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"JNJ":"强生"},"translate_title":"强生公司的一针Covid疫苗在欧洲获得批准，但供应问题依然存在","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JNJ":0.9},"content_text":"KEY POINTS\n\nEurope’s drug regulator on Thursday approved the one-dose coronavirus vaccine created by Johnson & Johnson.\nThe approval adds another weapon to the armory in use against the virus.\nSupply issues are expected to arise with this vaccine too, however.\n\nEurope’s drug regulator on Thursday approved the one-dose coronavirus vaccine created by Johnson & Johnson, adding another weapon in the armory being used to fight Covid-19.\nThe vaccine has the added benefit of only requiring a single dose and can be stored in most standard refrigerators at temperatures of 2 to 8 degrees Celsius (or roughly 36 to 46 degrees Fahrenheit), making it easier and cheaper to transport and store.\nOnce supplies start to be delivered, the shot could greatly bolster Europe’s struggling immunization program and is the fourth to be approved by the EMA. Two-dose vaccines developed by Pfizer-BioNTech,Moderna and AstraZeneca and the University of Oxford have also been approved.\nWhile it’s easier to distribute, the vaccine has not been found to be as effective as Pfizer and Moderna’s shots at preventing Covid infection. Nonetheless, the data shows it offers a decent level of protection:Clinical trial data from the U.S. has shown J&J’s vaccine is 72% effective at guarding against moderate to severe Covid(although it was found to be less potent in trials elsewhere, giving it an overall effectiveness of 66%), compared with about 95% for the other two vaccines.\nThe speed at which the EU will be able to roll out the J&J vaccine is not yet clear. The EU has ordered 200 million doses of the shot, with the option for 200 million more, Johnson & Johnson said in a statement last October.\nOn Wednesday, however, it was reported that, like other vaccine suppliers to the EU (Pfizer-BioNTech and AstraZeneca), supplies of the J&J vaccine to the bloc could be slower-than-expected.\nOne unnamed EU official told Reuters that Johnson & Johnson has told the EU it is facing supply issues that may complicate plans to deliver 55 million doses of its vaccine to the bloc in the second quarter of the year. CNBC has contacted J&J for further comment on the report and is yet to receive a response.\nFor its part, the European Commission, the EU’s executive arm, said on Wednesday that it has not been informed about any delays from J&J.\nA further delay in vaccine supplies would exacerbate the EU’s already lethargic vaccination rollout, which has struggled due to a slower ordering process than the U.K. and U.S., slower deliveries, bureaucracy and vaccine hesitancy.\nIn the U.S., J&J has a deal with the U.S. government to provide 100 million doses by the end of Juneand, on Wednesday, the Biden administration announced plans to buy 100 million additional doses.The announcement came as the White House works to ramp up production of the vaccine after it learned earlier in the year that the company had fallen behind in output.\nLast week,Biden announced that pharmaceutical giant Merck would help make J&J’s Covid vaccine. Under the arrangement, Merck will dedicate two facilities in the U.S. to J&J’s vaccine. One will make the vaccine and the other will provide “fill-finish” services, when the vaccine is placed in vials.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":20,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1124370726"}